Article Versions Notes

Chihanga T, Xu S, Fultz HN, Nicholson JD, Brombacher MD, Hawkins K, Fay DR, Steil MM, Ni S, Kennedy MA. How Early Can Pancreatic Tumors Be Detected Using NMR-Based Urine Metabolic Profiling? Identification of Early-Stage Biomarkers of Tumor Initiation and Progression in an Orthotopic Xenograft Mouse Model of Pancreatic Cancer. Metabolites. 2025; 15(3):142. https://doi.org/10.3390/metabo15030142

Chihanga, Tafadzwa, Shenyuan Xu, Hannah N. Fultz, Jenna D. Nicholson, Mark D. Brombacher, Kayla Hawkins, Dan R. Fay, Maria M. Steil, Shuisong Ni, and Michael A. Kennedy. 2025. "How Early Can Pancreatic Tumors Be Detected Using NMR-Based Urine Metabolic Profiling? Identification of Early-Stage Biomarkers of Tumor Initiation and Progression in an Orthotopic Xenograft Mouse Model of Pancreatic Cancer" Metabolites 15, no. 3: 142. https://doi.org/10.3390/metabo15030142

Chihanga, T., Xu, S., Fultz, H. N., Nicholson, J. D., Brombacher, M. D., Hawkins, K., Fay, D. R., Steil, M. M., Ni, S., & Kennedy, M. A. (2025). How Early Can Pancreatic Tumors Be Detected Using NMR-Based Urine Metabolic Profiling? Identification of Early-Stage Biomarkers of Tumor Initiation and Progression in an Orthotopic Xenograft Mouse Model of Pancreatic Cancer. Metabolites, 15(3), 142. https://doi.org/10.3390/metabo15030142